Obinutuzumab
Records for this ingredient, by country (identity only).
ATC L01FA03 · 12 markets · 16 records
AU 3 records · 2 shown of 2
- 1,000 mg/40 mLinjectionGazyva
- 1,000 mg per mL / per unit basis not statedinjectionGAZYVA obinutuzumab (rch) 1000 mg/40 mL concentrate solution for infusion vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 2 records · 1 shown of 1
- 1,000 mg/40 mLinjectionGazyvaro 1000mg/40ml concentrate for solution for infusion vials
ES 2 records · 1 shown of 1
- 1,000 mg per mL / per unit basis not statedinjectionGAZYVARO
US 1 records · 1 shown of 1
- 1,000 mg/40 mLinjectionGazyva
CA 1 records · 1 shown of 1
- 25 mg per mL / per unit basis not statedliquidGazyva
SG 1 records · 1 shown of 1
- 1,000 mg/40 mLinjectionGAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML
CN 1 records · 1 shown of 1
- 1,000 mg per mL / per unit basis not statedinjection佳罗华奥妥珠单抗
TW 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
JP 1 records · 1 shown of 1
- 1,000 mg/40 mLinjectionガザイバ点滴静注1000mg
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 shown of 1
- 1,000 mg per mL / per unit basis not statedinjectionGAZYVARO 1000 mg, solution à diluer pour perfusion
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | TW | HK | JP | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,000 mg/40 mLRecorded as: 1 g/40 mL injection | Gazyva | Gazyvaro 1000mg/40ml concentrate for solution for infusion vials | Gazyva | GAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML | ガザイバ点滴静注1000mg | |||||||
| 1,000 mg per mL / per unit basis not stated cannot compare injection | GAZYVA obinutuzumab (rch) 1000 mg/40 mL concentrate solution for infusion vial | 佳罗华奥妥珠单抗 | GAZYVARO | GAZYVARO 1000 mg, solution à diluer pour perfusion | ||||||||
| 25 mg per mL / per unit basis not stated cannot compare liquid | Gazyva | |||||||||||
unknown | Gazyva | GAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML | GAZYVARO | |||||||||
injection | Gazyva solution for infusion 癌即瓦注射劑 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in CA and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en CA que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 CA 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 CA 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.